Once-Daily Tacrolimus Shows Good Efficacy in 2-Year Follow-Up of Renal ... - DG News PDF Print
DG NewsSecondary endpoints included adverse events (AEs), renal function and the incidence of biopsy proven acute rejection (BPAR). ...Late Conversion to Sirolimus in Liver Transplant Recipients is a Safe Clinical

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.